table_specific

What is the average sales figure for the top 50% of Learningrx centers?

Learningrx Franchise · 2025 FDD

Answer from 2025 FDD Document

Sample: Top 25% Mid-Top Mid-Lower Bottom
25% 25% 25%
# of Centers: 11 10 10 10 4
Top Sales $893,375 $486,808 $287,188 $167,835 $376,730
Low Sales $507,737 $300,712 $172,105 $35,673 $133,094
Median Sales $601,971 $391,046 $229,711 $75,215 $195,526
Average Sales $631,577 $402,343 $229,935 $85,218 $225,219
Centers meeting or 2 / 18% 5 / 50% 5 / 50% 3 / 30% 1 / 25%
exceeding average:
Median Monthly Local $3,559 $3,107 $2,032 $879 $1,779
Marketing Expense
Sample: All Centers
Average Sales $333,848
Average Sales Top 50% $515,796

Source: Item 19 — FINANCIAL PERFORMANCE REPRESENTATIONS (FDD pages 46–48)

What This Means (2025 FDD)

According to Learningrx's 2025 Franchise Disclosure Document, the average sales for the top 50% of Learningrx centers is $515,796. This figure is based on data from centers open for the full year during the fiscal year ending September 30, 2024.

This financial performance representation provides prospective franchisees with an understanding of the potential revenue that can be generated by Learningrx centers. The top 50% average sales figure can be used as a benchmark for evaluating the potential profitability of a Learningrx franchise. It's important to note that this is an average, and individual center performance may vary.

It is important for potential franchisees to understand that the FDD states, "Some outlets have earned this amount. Your individual results may differ. There is no assurance that you'll earn as much." This highlights the inherent risk in any franchise investment, as success depends on various factors, including location, management skills, and local market conditions. Learningrx also states that written substantiation for the financial performance representation will be made available to the prospective franchisee upon reasonable request.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.